Cleared Special

K052121 - GEM PREMIER 3000

K052121 is the FDA 510(k) clearance for GEM PREMIER 3000 by Instrumentation Laboratory CO. It is a Class 2 Chemistry device (product code CGA) cleared through the Special 510(k) pathway after a 77-day FDA review.

K052121 · Instrumentation Laboratory CO · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2005
Decision
77d
Days
Class 2
Risk

K052121 is an FDA 510(k) clearance for the GEM PREMIER 3000. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on October 21, 2005 after a review of 77 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Instrumentation Laboratory CO devices

Submission Details

510(k) Number K052121 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2005
Decision Date October 21, 2005
Days to Decision 77 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 88d · This submission: 77d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 132
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K052121.
NOVA STATSTRIP XPRESS GLUCOSE HOSPITAL METER SYSTEM
K070960 · Nova Biomedical Corp. · Jul 2007
NOVA STATSTRIP GLUCOSE HOSPITAL METER SYSTEM
K063821 · Nova Biomedical Corp. · Jan 2007
NOVA STATSTRIP GLUCOSE HOSPITAL METER, STATSTRIP CONTROL SOLUTIONS
K060345 · Nova Biomedical Corp. · Apr 2006
RANDOX RX DAYTONA
K024014 · Randox Laboratories, Ltd. · Dec 2003
ASCENSIA BREEZE BLOOD GLUCOSE METER
K024062 · Bayer Corp. · Mar 2003
BACTON DICKINSON LATITUDE BLOOD GLUCOSE MONITORING SYSTEM
K022580 · Becton, Dickinson & CO · Oct 2002